Clearstead Advisors, LLC Novartis Ag Transaction History

Clearstead Advisors, LLC

$6.31 Billion
Q3 2024

A detailed history of Clearstead Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Clearstead Advisors, LLC holds 19,651 shares of NVS stock, worth $2.04 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

19,651

Previous 21,660 9.28%

Holding current value

$2.04 Million

Previous $2.31 Million 1.95%

% of portfolio

0.04%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $213,215 - $242,868	-2,009 Reduced 9.28%	19,651 $2.26 Million
Q2 2024 Aug 09, 2024	BUY	$92.57 - $107.37 $24,253 - $28,130	262 Added 1.22%	21,660 $2.31 Million
Q4 2023 Feb 12, 2024	SELL	$92.27 - $101.54 $138,220 - $152,106	-1,498 Reduced 6.54%	21,398 $2.16 Million
Q3 2023 Nov 07, 2023	BUY	$94.73 - $105.13 $2,084 - $2,312	22 Added 0.1%	22,896 $2.33 Million
Q2 2023 Aug 07, 2023	BUY	$92.52 - $104.91 $8,326 - $9,441	90 Added 0.4%	22,874 $2.31 Million
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $98,215 - $120,276	-1,300 Reduced 5.4%	22,784 $2.07 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $24,621 - $28,795	-330 Reduced 1.35%	24,084 $1.83 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $24,228 - $26,791	-304 Reduced 1.23%	24,414 $2.14 Million
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $34,347 - $39,958	-420 Reduced 1.67%	24,718 $2.02 Million
Q2 2021 Aug 12, 2021	SELL	$85.24 - $94.15 $260,919 - $288,193	-3,061 Reduced 10.85%	25,138 $2.29 Million
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $6,346 - $7,483	76 Added 0.27%	28,199 $2.41 Million
Q4 2020 Feb 11, 2021	BUY	$78.07 - $94.43 $7,650 - $9,254	98 Added 0.35%	28,123 $2.66 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $55,773 - $61,789	-679 Reduced 2.37%	28,025 $2.44 Million
Q2 2020 Aug 11, 2020	BUY	$80.93 - $91.1 $846,527 - $952,905	10,460 Added 57.33%	28,704 $2.51 Million
Q1 2020 May 14, 2020	SELL	$70.67 - $99.01 $26,147 - $36,633	-370 Reduced 1.99%	18,244 $1.5 Million
Q4 2019 Feb 11, 2020	SELL	$84.35 - $95.37 $14,002 - $15,831	-166 Reduced 0.88%	18,614 $1.76 Million
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $307,174 - $338,487	-3,591 Reduced 16.05%	18,780 $1.63 Million
Q2 2019 Aug 08, 2019	SELL	$75.4 - $92.8 $51,347 - $63,196	-681 Reduced 2.95%	22,371 $2.04 Million
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $2,560 - $2,929	-34 Reduced 0.15%	23,052 $2.22 Million
Q4 2018 Feb 11, 2019	BUY	$73.66 - $82.02 $47,658 - $53,066	647 Added 2.88%	23,086 $1.98 Million
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $40,164 - $46,458	600 Added 2.75%	22,439 $1.93 Million
Q2 2018 Aug 07, 2018	SELL	$64.91 - $73.36 $2,466 - $2,787	-38 Reduced 0.17%	21,839 $1.65 Million
Q1 2018 May 14, 2018	BUY	$70.39 - $84.15 $66,518 - $79,521	945 Added 4.51%	21,877 $1.77 Million
Q4 2017 Feb 09, 2018	SELL	$72.33 - $77.64 $87,880 - $94,332	-1,215 Reduced 5.49%	20,932 $1.76 Million
Q3 2017 Nov 09, 2017	BUY	$74.14 - $77.27 $1.64 Million - $1.71 Million	22,147	22,147 $1.9 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Account

Clearstead Advisors, LLC Novartis Ag Transaction History